Zyprexa was found to be more effective than lithium in helping patients with bipolar disorder remain in remission and prevent relapse into mania, according to new data presented at the Third European Stanley Foundation Conference on Bipolar Disorder. Pain & Central Nervous System Week via NewsEdge Corporation : Zyprexa was found to be more effective than lithium in helping patients with bipolar disorder remain in remission and prevent relapse into mania, according to new data presented at the Third European Stanley Foundation Conference on Bipolar Disorder. The year-long study showed that in the maintenance treatment of bipolar disorder, patients taking Zyprexa relapsed into mania only half as often as patients taking lithium, which has long been considered a standard of care for stabilizing mood in bipolar disorder. The two treatments were comparable with regard to preventing relapse into depression. In addition, significantly more Zyprexa-treated patients completed the study and significantly fewer were hospitalized. "While both drugs performed well, Zyprexa was found to be superior to lithium. This is especially impressive from a clinical standpoint given that lithium has been the gold standard for decades for the prevention of mania," said Frederick Goodwin, MD, director, Center on Neuroscience, Medical Progress, and Society, George Washington University Medical Center, Washington, DC. "This advance is very encouraging for the long-term treatment of the disease, meanwhile, we must continue our efforts to improve outcomes for bipolar depression." "What we have are two solid treatment options," said Mauricio Tohen, MD, PhD, Lilly Clinical Research Fellow, Lilly Research Laboratories. "This study provides further evidence that Zyprexa as a foundational treatment can help patients maintain dependable control in all phases of bipolar disorder, ultimately helping them to move their lives forward." This article was prepared by Pain & Central Nervous System Week editors from staff and other reports. <> << Copyright ©2002 NewsRx.com >>
ФГБНУ НЦПЗ, совместно с РОП, проводит 6-я Костромскую Всероссийскую школу молодых ученых и специалистов в области психического здоровья «Психические заболевания в условиях современных социальных вызовов: возрастные аспекты» 03 октября, 2024
ФГБНУ НЦПЗ совместно с РОП, при участии СОПЗ, проводит Юбилейную Всероссийскую Научно-практическую конференцию с международным участием, посвященную 80-летию НЦПЗ 06 июня, 2024
ФГБНУ НЦПЗ совместно с РОП проводит Всероссийскую конференции молодых ученых, посвященную 120-летию со дня рождения академика А.В. Снежневского. Во вложенных документах - более подробная информация о конференциях и о возможностях принять участие. 21 мая, 2024
Конференция с международным участием «Биполярное аффективное расстройство: весеннее обострение» 28 марта, 2024
8 февраля отмечается День российской науки. Т.П. Клюшник, д.м.н., профессор, директор ФГБНУ НЦПЗ, поздравила работников Центра с праздником, отметив их ценный вклад в науку, и пожелала новых успехов, идей и открытий. 08 февраля, 2024